Spotlight on Alexion's pricing of rare-disease drug Soliris

Thursday, June 25, 2015 - 04:30 in Mathematics & Economics

A special drug for an extremely rare disease, Soliris costs about half a million dollars per patient, per year, for life. Why? The reasons for the price are locked in "the black box" of drug pricing that governments are seeking to crack open.

Read the whole article on CBC: Health

More from CBC: Health

Learn more about

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net